| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |